<img src="https://secure.intelligence52.com/795232.png" style="display:none;">

Blog

What are Biosimilars? Definitions, Uses & Key Risks

By Statistical Consultancy Team
October 30, 2026
Biosimilars are highly similar to approved biologics, with no clinically meaningful differences. See how they’re approved, used and where the risks lie.
Learn more

Using R Programming for Clinical Trial Data Analysis

By Clinical Programming Team
October 28, 2026
See where R programming fits across clinical trial data analysis, from study planning and safety analysis to validated TLF production.
Learn more

Bayesian Statistics: How it Works and When to Use it

By Statistical Consultancy Team
October 23, 2026
See how Bayesian statistics works through a diagnostic testing example, including prior probabilities, posterior estimates, and uncertainty.
Learn more

Health Economics and Outcomes Research (HEOR) and Real-World Evidence

By Clinical Programming Team
October 21, 2026
Explore health economics and outcomes research (HEOR), including RWE, HTA, real-world datasets and programming considerations.
Learn more

Protocol Amendments in Clinical Trials: Requirements and Impact

By Clinical Data Management Team
September 25, 2026
Explore how protocol and mid-study amendments in clinical trials can change study conduct, data collection, and analysis.
Learn more

Multi-Omics in Clinical Research: Choosing an Integration Strategy

By Statistical Consultancy Team
September 24, 2026
See how clinical multi-omics data is integrated and analysed, where single-cell and spatial methods fit, and what can limit wider clinical use.
Learn more

Equivalence Trials: Design, Analysis & Interpretation

By Statistical Consultancy Team
September 17, 2026
See how equivalence trials are designed and analysed, including margins, confidence intervals, sample size, assay sensitivity and re-randomisation.
Learn more

Longitudinal Observational Data in Paediatric Disease Registries

By Statistical Consultancy Team
September 11, 2026
How longitudinal observational data from registries can inform growth, maturation and safety analyses, with key risks around bias and follow-up.
Learn more

Tipping Point Analysis in Clinical Trials

By Statistical Consultancy Team
September 9, 2026
Understand tipping point analysis in clinical trials, including MAR, MNAR, delta shifts, endpoint types, and key limitations.
Learn more

Clinical Trial Planning and Design: What to Plan Before Execution

By Statistical Consultancy Team
September 4, 2026
See how clinical trial planning and design connects the research question with population, endpoints, comparator choice, analysis and feasibility.
Learn more

What is a Clinical Development Plan (CDP) and What Should It Include?

By Statistical Consultancy Team
September 2, 2026
Understand how a clinical development plan supports cross-functional decisions, regulatory interactions, risk planning and trial delivery.
Learn more

Clinical Trial Trends Shaping Modern Drug Development

By Commercial Team
August 28, 2026
Explore clinical trial trends affecting the future of clinical trials, including DCTs, PROs, advanced therapies and outsourcing.
Learn more

Subscribe to the Blog